Related Experiment Video
Updated: May 31, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Combined survival analysis of cardiac patients by a Cox PH model and a Markov chain
Michal Shauly1, Gad Rabinowitz, Harel Gilutz
1Department of Industrial Engineering and Management, Ben-Gurion University of the Negev, P.O. Box 653, Beer-Sheva 84105, Israel. shauly@bgu.ac.il
Insights
This study introduces a novel framework combining Cox PH and Markov models to analyze cardiac patient survival. The findings highlight key risk factors and the survival benefits of statin use in coronary heart disease patients.
Area of Science:
- Cardiovascular Medicine
- Biostatistics
- Public Health
Background:
- Dyslipidemia management is crucial for patients with coronary heart diseases, posing a significant public health challenge.
- Understanding factors influencing survival after major cardiac events is essential for effective patient care and disease prevention.
Purpose of the Study:
- To develop and validate a combined Cox Proportional Hazards (PH) model and Markov chain framework for survival analysis in cardiac patients.
- To assess the impact of changing Low-Density Lipoprotein (LDL)-cholesterol levels and statin consumption on patient survival post-cardiac event.
Main Methods:
- Prospective study of 2,277 cardiac patients.
- Application of a combined framework integrating Cox PH model and Markov chain analysis.
- Evaluation of factors affecting survival time, hazard rates, and long-term outcomes.
Main Results:
- High congruence observed between the Markov and Cox PH models.
- Diabetes, history of stroke, peripheral vascular disease, and smoking were identified as significant predictors of increased hazard rate and reduced survival time.
- Statin consumption was consistently correlated with a lower hazard rate and longer survival time across both models.
Conclusions:
- The proposed framework effectively integrates different modeling approaches to provide robust conclusions on survival factors in cardiac patients.
- Findings underscore the importance of managing comorbidities and lifestyle factors (e.g., smoking) alongside statin therapy for improving cardiac patient survival.
- The framework offers valuable insights for understanding therapeutic behaviors and implementing targeted secondary and primary prevention strategies for heart diseases.
Abstract:
The control and treatment of dyslipidemia is a major public health challenge, particularly for patients with coronary heart diseases. In this paper we propose a framework for survival analysis of patients who had a major cardiac event, focusing on assessment of the effect of changing LDL-cholesterol level and statins consumption on survival. This framework includes a Cox PH model and a Markov chain, and combines their results into reinforced conclusions regarding the factors that affect survival time. We prospectively studied 2,277 cardiac patients, and the results show high congruence between the Markov model and the PH model; both evidence that diabetes, history of stroke, peripheral vascular disease and smoking significantly increase hazard rate and reduce survival time. On the other hand, statin consumption is correlated with a lower hazard rate and longer survival time in both models. The role of such a framework in understanding the therapeutic behavior of patients and implementing effective secondary and primary prevention of heart diseases is discussed here.
Related Concept Videos
Comparing the Survival Analysis of Two or More Groups
Cancer Survival Analysis
Assumptions of Survival Analysis
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time until a...
The Mantel-Cox Log-Rank Test
Kaplan-Meier Approach

